Investment Analysts’ Weekly Ratings Updates for IDEX (IEX)

Several analysts have recently updated their ratings and price targets for IDEX (NYSE: IEX):

  • 2/2/2018 – IDEX was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $162.00 price target on the stock. According to Zacks, “IDEX reported strong fourth-quarter 2017 results with healthy year-over-year increase in earnings and revenues, driven by modest organic growth and diligent execution of operational plans. The company is currently striving to expand its businesses in the emerging markets by focusing on organic growth. The company intends to optimize its cost structure, increase its competitiveness and reallocate resources to improve profitability. IDEX further aims to increase its market exposure and improve sales mix by continually developing new products. With a flexible yet disciplined focus on cost and productivity, the company expects to successfully tap newer markets. IDEX has offered a bullish guidance for 2018. The company also outperformed the industry in the past three months. However, IDEX has huge recurring R&D expenses, which increase operating costs and reduce price control over products and limit its growth potential to some extent.”
  • 2/1/2018 – IDEX had its price target raised by analysts at SunTrust Banks, Inc. to $145.00. They noted that the move was a valuation call. They noted that the move was a valuation call.
  • 1/31/2018 – IDEX had its price target raised by analysts at BMO Capital Markets to $143.00. They now have a “market perform” rating on the stock. They noted that the move was a valuation call. They noted that the move was a valuation call.
  • 1/31/2018 – IDEX had its “positive” rating reaffirmed by analysts at Wells Fargo & Co. They now have a $165.00 price target on the stock, up previously from $155.00.
  • 1/28/2018 – IDEX had its “hold” rating reaffirmed by analysts at Cowen Inc. They now have a $120.00 price target on the stock.
  • 1/22/2018 – IDEX is now covered by analysts at UBS Group AG. They set a “neutral” rating on the stock.
  • 1/18/2018 – IDEX was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “IDEX is currently striving to expand its businesses in the emerging markets by focusing on organic growth. IDEX further aims to increase its market exposure and improve sales mix by continually developing new products. With a flexible yet disciplined focus on cost and productivity, IDEX expects to successfully tap newer markets to augment its revenue. IDEX also outperformed the industry in the past three months. However, IDEX has huge recurring R&D expenses, which increase operating costs and reduce price control over products. Also, IDEX is susceptible to various operating risks related to the availability and prices for raw materials as it procures substantial amount of components from suppliers across the globe. With operations across five continents, IDEX’s performance is exposed to the adverse impact of macroeconomic cycles in the United States and international markets.”
  • 1/18/2018 – IDEX was given a new $155.00 price target on by analysts at Wells Fargo & Co. They now have a “buy” rating on the stock.
  • 1/16/2018 – IDEX had its “hold” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $145.00 price target on the stock, up previously from $132.00.
  • 12/18/2017 – IDEX was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “With a flexible yet disciplined focus on cost and productivity, IDEX expects to successfully tap newer markets to boost its revenue. The company intends to optimize its cost structure, increase competitiveness and reallocate resources to improve profitability. With diligent execution of operational plans, IDEX outperformed the industry year to date. Management also raised its earlier guidance for 2017 on solid third-quarter results, robust demand patterns and healthy growth dynamics. However, huge recurring R&D expenses increase operating costs and reduce price control over products, which often result in the loss of market share, poor sales and lower operating margins. In addition, the company’s business strategy hinges on acquiring companies and making investments that complement its existing businesses. These acquisitions entail huge integration costs which often become a drag on the profitability of IDEX.”
  • 12/15/2017 – IDEX had its “buy” rating reaffirmed by analysts at Robert W. Baird. They now have a $141.00 price target on the stock.
  • 12/14/2017 – IDEX had its “hold” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $132.00 price target on the stock.

IDEX Co. (IEX) opened at $130.90 on Monday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.06 and a current ratio of 2.78. The company has a market cap of $10,001.00, a price-to-earnings ratio of 30.02, a price-to-earnings-growth ratio of 1.99 and a beta of 1.25. IDEX Co. has a one year low of $89.69 and a one year high of $148.32.

IDEX (NYSE:IEX) last posted its quarterly earnings data on Monday, January 29th. The industrial products company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.07 by $0.05. The company had revenue of $585.90 million during the quarter, compared to analyst estimates of $573.47 million. IDEX had a net margin of 14.74% and a return on equity of 18.88%. IDEX’s quarterly revenue was up 10.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.96 earnings per share. equities analysts anticipate that IDEX Co. will post 5.07 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, January 30th. Shareholders of record on Monday, January 15th were paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend was Thursday, January 11th. IDEX’s payout ratio is 33.95%.

IDEX Corporation (IDEX) operates an applied solutions business that sells pumps, flow meters and other fluidics systems, and components and engineered products. The Company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP).

Receive News & Ratings for IDEX Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX Co and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply